Despite Rising Rates Of Depression, It’s Doubtful We’ll See
It is likely to be at least 10 years before any new generation of antidepressants comes to market, despite evidence that depression and anxiety rates are increasing across the world, specialists said on Wednesday.

The depression drug pipeline has run dry partly due to a “failure of science” they said, but also due to big pharma pulling investment out of research and development (R&D) in the neuroscience field because the profit potential is uncertain.

“I’d be very surprised if we were to see any new drugs for depression in the next decade. The pharmaceutical industry is simply not investing in the research because it can’t make money from these drugs,” Guy Goodwin, a professor of psychiatry at the University of Oxford, told reporters at a London briefing....

http://www.huffingtonpost.com/entry/despite-rising-rates-of-depression-its-doubtful-well-see-new-drugs_us_587e5343e4b0f63fcfa33a26
Like
Comment
Share